Parenteral Iron Therapy in Cancer-Associated Anemia

Author:

Henry David H.1

Affiliation:

1. Joan Karnell Cancer Center at Pennsylvania Hospital, Philadelphia, PA, USA

Abstract

AbstractAnemia is common in cancer patients. Its cause is multifactorial, so a brief workup is always necessary to rule out simple, reversible causes. Anemia of chronic disease/inflammation and chemotherapy-induced anemia are the most common causes. Symptomatic or clinically severe anemia may require treatment with blood transfusion or an erythropoiesis-stimulating agent (ESA). If ESA therapy is chosen, developing evidence now suggests that, similar to chronic renal failure patients on hemodialysis, the addition of intravenous iron can improve the response to ESA because of iron-restricted erythropoiesis, even in the iron-replete patient.

Publisher

American Society of Hematology

Subject

Hematology

Reference54 articles.

1. Iron or vitamin B12 deficiency in anemic cancer patients prior to erythropoiesis-stimulating agent therapy;Henry;Community Oncology,2007

2. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation;Shord;J Am Pharm Assoc,2008

3. Anemia of chronic disease;Weiss;N Engl J Med,2005

4. Advances in the anemia of chronic disease;Means;Int J Hematol,1999

5. The anemia of inflammation/malignancy: mechanisms and management;Adamson;Hematology Am Soc Hematol Educ Program,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3